Magstim, developer of transcranial magnetic stimulation products, has reached agreement with Royal Philips to acquire the product portfolio of Electrical Geodesics, adding to Magstim’s breadth of products and technology. The company also recently appointed a new chief technology officer.
“This adds high-density EEG to our product portfolio supporting more than 1,200 research labs and clinics that focus on mental health, brain disorders and cognitive neuroscience,” said Lothar Krinke, Group CEO for Magstim.
“Magstim has been pioneering and advancing transcranial magnetic stimulation for 30 years. High-density EEG closes the loop for the development of a comprehensive system for non-invasive neuromodulation.”
Electroencephalography (EEG) is used to evaluate the electrical activity in the brain. EGI’s proprietary dense array EEG technology gathers data from more electrodes than conventional systems. Its Geodesic Sensor Net, shown at top, is used globally by neuroscience researchers because of its ease of use, comfort and ability to produce high-resolution data. Transcranial Magnetic Stimulation (TMS) is both aa research tool and a non-invasive, outpatient therapy that is cleared by the FDA for major depressive disorder.
In August, Magstim announced the appointment of Lucien van Os as chief technology officer to lead product and technology development for its Magstim TMS, Electrical Geodesics, Technomed and Neurosign brands. He will lead product technology and manage the group’s patent portfolio and research collaborations. “Lucien is globally recognized for his medical device technology leadership at Medtronic, Gambro/Baxter, Sphere Medical, TMSi, Philips, and Ericsson,” noted Krinke. For more info, see www.magstim.com.
